Multiple US states have passed laws limiting the ability to terminate a pregnancy affected by Down syndrome or other genetic conditions, with the Ohio version of this law recently upheld by the US Sixth Circuit Court of Appeals (Preterm Cleveland v. McCloud). Yet historically, the relationship between prenatal genetics and abortion has always been complex. Options for prenatal genetic screening, diagnosis, and intervention have increased dramatically, but data suggest that a majority of pregnant people who receive a fetal genetic diagnosis in the US choose to terminate their pregnancy. If laws curtailing or eliminating the option of abortion in these cases are upheld, what role can and should genetics play in prenatal care?
Panelist: Ellen Wright Clayton, MD, JD (Vanderbilt University)
Panelist: Marsha Michie, PhD (Case Western University)
Moderator: Laura Hercher, MA, MS (Sarah Lawrence College)
To continue the conversation please join fellow audience members for an informal discussion in a Zoom meeting immediately following the forum. The link will be placed in the Zoom Chat during the forum. For those who cannot attend the live event, the forum will be recorded and archived on the ELSIhub Video page.
Closed captioning and/or transcripts will be provided for live and recorded events.
By registering for an ELSIhub event, attendees agree to abide by the ELSIhub Code of Conduct: https://elsihub.org/news/code-conduct